Taiwan Liposome Company Ltd Annual Return on Equity ROE, Trends, Fundamental Ratios - CSIMarket
CSIMarket
 


Taiwan Liposome Company Ltd   (NASDAQ: TLC)

TLC's ROE over the last five Years

Return on Equity, Annual Results, Trends, Rankings, Statistics


Return On Equity (Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018


Y / Y Equity Change 27.38 % 10.41 % - - -
Y / Y Net Income Change - - - - -
Return On Equity - - - - -


You need to upgrade your Flash Player


Financial Statements
Taiwan Liposome Ltd 's Equity $ 31 Millions Annual TLC's Balance sheet
Taiwan Liposome Ltd 's Annual Income $ -35 Millions Annual TLC's Income Statement
Where are TLC's Income coming from? Visit TLC's Income by Segment





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.